Although surface proteins such as CD44 and CD133 have been widely used to isolate CSC populations, these markers are not exclusive to CSCs and are often expressed in normal stem cells (NSCs) or non-tumorigenic cancer cells.1,2 Moreover, their expression varies across tumor types, reflecting the influence of tissue origin and the microenvironmental context on CSC phenotypes. The gene discussed is CD44; the disease is cancer.